Scri Development Innovations, Llc

This study tested a new drug called U3-1402 in 121 patients whose breast cancer had spread or was locally advanced. The main goal was to see if the drug was safe and if it could shrink tumors or stop the cancer from growing for at least six months. Researchers also looked at how …